CACLP 2024 | Zybio Product Launch Made An Impression
March 16, 2024 Zybio News
-
April 21, 2025
DiagHub Online Academic Platform: The First Session on Clinical Chemistry Concludes Successfully
-
April 16, 2025
Higher Accuracy While ~40% Time Saved: Reliable Dispersion Method of Zybio MALDI-TOF MS Platform Boosting Identification Rates
-
April 16, 2025
~94% Accuracy While Shortening TAT to 5 Minutes: Explore Zybio MALDI-TOF MS with Advanced Rapid Blood Culture Enrichment Technology
On March 16th, Zybio held product launch at CACLP 2024, presenting EXT 9800 Fully-Automated Coagulation Analyzer and EXI 8000 Fully-Automated Chemiluminescence Immunoassay Analyzer. Focusing on user's needs, Zybio offers a series of products integrating advanced technologies, and in this way, we strive to bring innovative breakthroughs in the field of medical diagnostics.
A Glance of New Products
EXT 9800 Fully-Automated Coagulation Analyzer
To meet the need from laboratory for increasing precision, Zybio adheres to innovation and is committed to solving the underlying challenges for users. EXT 9800 Fully-Automated Coagulation Analyzer is the first to adopt micro magnetic particle detection method, which visualizes coagulation analysis and provides multi-dimensional analysis of coagulation process, thus enabling more accurate and in-depth analysis. EXT 9800 redefines automated detection system, creatively constructs distributed detection structure, enables modular expandability, and provides high-throughput and lightweight total solution for laboratories. Furthermore, EXT 9800 has a comprehensive upgrade throughout the analysis process, in pursuit of quality excellence, marking a new chapter in the innovative development of coagulation testing.
EXI 8000 Fully-Automated CLIA Analyzer
The emergence of Chinese chemiluminescence immunoassay equipment brand relies on technological breakthroughs and innovations. At CACLP 2024, Zybio launched the fully-automated chemiluminescence immunoassay analyzer EXI 8000, which exceeds the limit of immunoassay testing speed with a throughput of up to 800 tests/hour, and is a leading ultra-high-speed CLIA platform that is independently developed and manufactured by Zybio. The instrument integrates the innovative dual sample handling system and reagent auto-loading module, which enables high throughput, long walk-away time, automatic quality control, etc. The highly sensitive optical sensor, precise temperature control system and multi-cleaning mode guarantee the reliability of the detection results. In addition, we innovate and empower the management of reagents and consumables, quality control management and operation mode, so as to transform technology-based laboratory into management-based one. High peed for efficiency, superb quality for excellence——with robust functions, intelligent operation system and comprehensive test menu, EXI 8000 is designed to bring users experience of intelligence, simplifying testing and improving quality together with efficiency.
CACLP 2024 witnessed Zybio's comprehensive diagnostic solution for healthcare institutions with biochemistry, immunoassay, mass spectrometry, thrombosis, hematology, urinalysis, molecular and point-of-care testing, etc. With full-range technical support and after-sale service, Zybio ensures that these innovative products are accessible to healthcare providers and are fully utilized. Training and technical support are provided to accelerate new technologies in reaching healthcare facilities and to improve service quality.